Three new vice presidents have joined the executive ranks of brachytherapy provider Nucletron.
Nucletron expands exec ranks
Three new vice presidents have joined the executive ranks of brachytherapy provider Nucletron. As vice president of global marketing, Jan Boers will be responsible for worldwide marketing and communications, joining the firm after serving in roles at CSM Food, Heinz, and Sara Lee International. John Lapré takes over as Nucletron's vice president of research and development following his most recent stint as VP of research and development for CP Kelco. Bringing nearly 20 years of international experience in the pharmaceutical industry, Dr. Jonathan Briers leads the company’s newly created medical affairs department, having served in product management and medical affairs at Servier International, SmithKline Beecham and, most recently, at Pfizer. Briers previously held appointments at the University of Manchester Medical School in the U.K. and clinical posts in Manchester and Liverpool.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.